Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 1 results out of 1                                
                                
                                                Data Insights
                                                
                                        BRL-101 by BRL Medicine for Sickle Cell Disease: Likelihood of Approval
BRL-101 is under clinical development by BRL Medicine and currently in Phase II for Sickle Cell Disease. According to GlobalData,...
